Find A Research Study
Gastroenterology
Virginia Mason's Section of Gastroenterology is nationally and internationally recognized as one of the top gastroenterology departments. U.S. News & World Report has repeatedly ranked the section as one of the top 30 in the United States. Our research program looks closely into how to continuously improve our patients' well-being as they are being treated for diseases and disorders of the stomach, colon, liver, and pancreas.
To participate in a BRI clinical trial, please contact the study coordinator listed in each of the study links below, or send an e-mail to the Clinical Research Program. Please click on individual studies for more information.
Studies currently accepting study participants:
- 5-arm, parallel-group study of the effects on viral kinetics, safety and pharmacokinetics of different dosing regimens of Debio 025 in combination with peginterferon alpha-2a and ribavirin in chronic HCV genotype 1 patients who non-responders to standard
- 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus
- 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus
- A Phase IIb, Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Multicenter Study to Determine the Safety, Tolerance, and Efficacy of AT-1001 in Celiac Disease Subjects during a Gluten Challenge.
- A Randomized Phase II/III of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer
- Abatacept in Treatment of Patient with Active Crohns Disease (CD) who have had an Inadequate Clinical Response and/or Intolerance to Medical Therapy
- Abatacept in Treatment of Patient with Active Ulcerative Colitis (UC) who have had an Inadequate Clinical Response and/or Intolerance to Medical Therapy
- Evaluation of PillCam® ESO 2 in Patients with Suspected Esophageal Pathologies
- Liver Disease Registry and Tissue Repository
- RG1068 (Synthetic Human Secretin) – Enhanced MRCP in the Evaluation of Subjects with a History of Acute or Acute Recurrent Pancreatitis
Studies currently not accepting study participants:
No studies currently listed. Please try another category.